Exelixis Inc Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Exelixis Inc (EXEL) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$1.60 million for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-05
- Exelixis Inc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-07-03 was -$1.60M.
- Exelixis Inc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-04-03 was -$3.89M, a 215.91% decline year-over-year.
- Exelixis Inc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-01-02 was -$89.00K.
- Exelixis Inc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-10-03 was $2.22M, a 75.66% decline year-over-year.
- Exelixis Inc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2026 was $4.82M, a 100.71% increase from fiscal 2025.
- Exelixis Inc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $2.40M, a 77.69% decline from fiscal 2023.
- Exelixis Inc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $10.77M.
- Exelixis Inc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$13.76M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-07-03 | -$1.60M 10-Q · filed 2026-08-05 | -$5.49M 10-Q · filed 2026-08-05 | -$5.58M derived: sum of 3 quarters · filed 2026-08-05 | -$3.36M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-04-03 | -$3.89M 10-Q · filed 2026-05-05 | -$3.98M derived: sum of 2 quarters · filed 2026-05-05 | -$1.76M derived: sum of 3 quarters · filed 2026-05-05 | -$2.42M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-01-02 | -$89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $2.13M derived: sum of 2 quarters · filed 2026-02-10 | $1.47M derived: sum of 3 quarters · filed 2026-08-05 | $4.82M 10-K · filed 2026-02-10 |
| 2025-10-03 | $2.22M 10-Q · filed 2025-11-04 | $1.55M derived: sum of 2 quarters · filed 2026-08-05 | $4.91M 10-Q · filed 2025-11-04 | -$391.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-07-04 | -$661.00K 10-Q · filed 2026-08-05 | $2.70M 10-Q · filed 2026-08-05 | -$2.61M derived: sum of 3 quarters · filed 2026-08-05 | $6.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-04-04 | $3.36M 10-Q · filed 2026-05-05 | -$1.95M derived: sum of 2 quarters · filed 2026-05-05 | $7.16M derived: sum of 3 quarters · filed 2026-05-05 | $7.21M derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-01-03 | -$5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $3.80M derived: sum of 2 quarters · filed 2026-02-10 | $3.86M derived: sum of 3 quarters · filed 2026-02-10 | $2.40M 10-K · filed 2026-02-10 |
| 2024-09-27 | $9.11M 10-Q · filed 2025-11-04 | $9.16M derived: sum of 2 quarters · filed 2025-11-04 | $7.71M 10-Q · filed 2025-11-04 | $17.97M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-28 | $55.00K 10-Q · filed 2025-07-28 | -$1.40M 10-Q · filed 2025-07-28 | $8.86M derived: sum of 3 quarters · filed 2026-02-10 | $9.29M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-29 | -$1.45M 10-Q · filed 2025-05-13 | $8.81M derived: sum of 2 quarters · filed 2026-02-10 | $9.23M derived: sum of 3 quarters · filed 2026-02-10 | $4.08M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-29 | $10.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $10.69M derived: sum of 2 quarters · filed 2026-02-10 | $5.54M derived: sum of 3 quarters · filed 2026-02-10 | $10.77M 10-K · filed 2026-02-10 |
| 2023-09-29 | $425.00K 10-Q · filed 2024-10-29 | -$4.72M derived: sum of 2 quarters · filed 2024-10-29 | $509.00K 10-Q · filed 2024-10-29 | $3.53M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | -$5.15M 10-Q · filed 2024-08-06 | $84.00K 10-Q · filed 2024-08-06 | $3.10M derived: sum of 3 quarters · filed 2025-02-11 | -$5.52M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $5.23M 10-Q · filed 2024-04-30 | $8.25M derived: sum of 2 quarters · filed 2025-02-11 | -$372.00K derived: sum of 3 quarters · filed 2025-02-11 | -$2.62M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-30 | $3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | -$5.60M derived: sum of 2 quarters · filed 2025-02-11 | -$7.86M derived: sum of 3 quarters · filed 2025-02-11 | -$13.76M 10-K · filed 2025-02-11 |
| 2022-09-30 | -$8.62M 10-Q · filed 2023-11-01 | -$10.87M derived: sum of 2 quarters · filed 2023-11-01 | -$16.78M 10-Q · filed 2023-11-01 | -$19.02M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-07-01 | -$2.25M 10-Q · filed 2023-08-01 | -$8.16M 10-Q · filed 2023-08-01 | -$10.40M derived: sum of 3 quarters · filed 2024-02-06 | -$10.90M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-04-01 | -$5.91M 10-Q · filed 2023-05-09 | -$8.15M derived: sum of 2 quarters · filed 2024-02-06 | -$8.65M derived: sum of 3 quarters · filed 2024-02-06 | -$9.40M derived: sum of 4 quarters · filed 2024-02-06 |
| 2021-12-31 | -$2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-06 | -$2.74M derived: sum of 2 quarters · filed 2024-02-06 | -$3.50M derived: sum of 3 quarters · filed 2024-02-06 | -$5.23M 10-K · filed 2024-02-06 |
| 2021-10-01 | -$504.00K 10-Q · filed 2022-11-01 | -$1.26M derived: sum of 2 quarters · filed 2022-11-01 | -$3.00M 10-Q · filed 2022-11-01 | -$4.76M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-07-02 | -$755.00K 10-Q · filed 2022-08-09 | -$2.49M 10-Q · filed 2022-08-09 | -$4.25M derived: sum of 3 quarters · filed 2023-02-07 | -$5.86M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-04-02 | -$1.74M 10-Q · filed 2022-05-10 | -$3.50M derived: sum of 2 quarters · filed 2023-02-07 | -$5.10M derived: sum of 3 quarters · filed 2023-02-07 | $2.96M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-01-01 | -$1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | -$3.36M derived: sum of 2 quarters · filed 2023-02-07 | $4.70M derived: sum of 3 quarters · filed 2023-02-07 | $1.41M 10-K · filed 2023-02-07 |
| 2020-10-02 | -$1.60M 10-Q · filed 2021-11-02 | $6.46M derived: sum of 2 quarters · filed 2021-11-02 | $3.17M 10-Q · filed 2021-11-02 | $3.57M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-07-03 | $8.06M 10-Q · filed 2021-08-05 | $4.77M 10-Q · filed 2021-08-05 | $5.17M derived: sum of 3 quarters · filed 2022-02-18 | $5.63M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-04-03 | -$3.29M 10-Q · filed 2021-05-06 | -$2.89M derived: sum of 2 quarters · filed 2022-02-18 | -$2.43M derived: sum of 3 quarters · filed 2022-02-18 | -$950.00K derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-01-03 | $401.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $862.00K derived: sum of 2 quarters · filed 2022-02-18 | $2.34M derived: sum of 3 quarters · filed 2022-02-18 | $3.77M 10-K · filed 2022-02-18 |
| 2019-09-27 | $461.00K 10-Q · filed 2020-11-05 | $1.94M derived: sum of 2 quarters · filed 2020-11-05 | $3.37M 10-Q · filed 2020-11-05 | $3.18M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-28 | $1.48M 10-Q · filed 2020-08-06 | $2.91M 10-Q · filed 2020-08-06 | $2.72M derived: sum of 3 quarters · filed 2020-08-06 | $2.94M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-29 | $1.43M 10-Q · filed 2020-05-05 | $1.24M derived: sum of 2 quarters · filed 2020-05-05 | $1.46M derived: sum of 3 quarters · filed 2020-05-05 | $1.61M derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-28 | -$188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $30.00K derived: sum of 2 quarters · filed 2020-02-25 | $186.00K derived: sum of 3 quarters · filed 2020-02-25 | -$354.00K 10-K · filed 2021-02-11 |
| 2018-09-28 | $218.00K 10-Q · filed 2019-10-30 | $374.00K derived: sum of 2 quarters · filed 2019-10-30 | -$166.00K 10-Q · filed 2019-10-30 | -$461.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-29 | $156.00K 10-Q · filed 2019-07-31 | -$384.00K 10-Q · filed 2019-07-31 | -$679.00K derived: sum of 3 quarters · filed 2020-02-25 | -$612.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-30 | -$540.00K 10-Q · filed 2019-05-01 | -$835.00K derived: sum of 2 quarters · filed 2020-02-25 | -$768.00K derived: sum of 3 quarters · filed 2020-02-25 | |
| 2017-12-29 | -$295.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$228.00K derived: sum of 2 quarters · filed 2020-02-25 | $69.00K 10-K · filed 2020-02-25 | |
| 2017-09-30 | $67.00K 10-Q · filed 2017-11-01 | $364.00K 10-Q · filed 2017-11-01 | ||
| 2017-09-29 | $67.00K 10-Q · filed 2018-11-01 | $274.00K derived: sum of 2 quarters · filed 2018-11-01 | $364.00K 10-Q · filed 2018-11-01 | $28.00K derived: sum of 4 quarters · filed 2018-11-01 |
| 2017-06-30 | $207.00K 10-Q · filed 2018-08-01 | $297.00K 10-Q · filed 2017-08-02 | -$39.00K derived: sum of 3 quarters · filed 2018-08-01 | -$248.00K derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-03-31 | $90.00K 10-Q · filed 2017-05-01 | -$246.00K derived: sum of 2 quarters · filed 2018-05-02 | -$455.00K derived: sum of 3 quarters · filed 2018-05-02 | -$284.00K derived: sum of 4 quarters · filed 2018-05-02 |
| 2016-12-31 | -$336.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$545.00K derived: sum of 2 quarters · filed 2017-11-01 | -$374.00K derived: sum of 3 quarters · filed 2017-11-01 | -$184.00K 10-K · filed 2017-02-27 |
| 2016-12-30 | -$184.00K 10-K · filed 2019-02-22 | |||
| 2016-09-30 | -$209.00K 10-Q · filed 2017-11-01 | -$38.00K derived: sum of 2 quarters · filed 2017-11-01 | $152.00K 10-Q · filed 2017-11-01 | |
| 2016-06-30 | $171.00K 10-Q · filed 2017-08-02 | $361.00K 10-Q · filed 2017-08-02 | ||
| 2016-03-31 | $190.00K 10-Q · filed 2017-05-01 | |||
| 2016-01-01 | -$111.00K 10-K · filed 2018-02-26 | |||
| 2015-12-31 | -$111.00K 10-K · filed 2017-02-27 | |||
| 2014-12-31 | -$267.00K 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |